{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Alcoholic liver disease", "Cirrhosis", "Efficacy", "Fungal bioactive compounds", "Fusarium oxysporum", "Hepatic disorders", "Liver inflammatory disease", "Non-alcoholic fatty liver disease", "Oxidative stress", "Therapeutic effects"]], "OtherAbstract": [], "SpaceFlightMission": [], "InvestigatorList": [], "CitationSubset": [], "OtherID": [], "GeneralNote": [], "PMID": "38455549", "DateRevised": {"Year": "2024", "Month": "03", "Day": "09"}, "Article": {"Language": ["eng"], "ELocationID": ["e26562", "10.1016/j.heliyon.2024.e26562"], "ArticleDate": [{"Year": "2024", "Month": "02", "Day": "20"}], "Journal": {"ISSN": "2405-8440", "JournalIssue": {"Volume": "10", "Issue": "5", "PubDate": {"Year": "2024", "Month": "Mar", "Day": "15"}}, "Title": "Heliyon", "ISOAbbreviation": "Heliyon"}, "ArticleTitle": "Protective effects of hepatic diseases by bioactive phytochemicals in <i>Fusarium oxysporum -</i> A review.", "Pagination": {"StartPage": "e26562", "MedlinePgn": "e26562"}, "Abstract": {"AbstractText": ["Lately, liver diseases were categorized as one of the most prevalent health problems globally as it causes a severe threat to mankind all over the world due to the wide range of occurrence. There are multiple factors causing hepatic disorders, such as alcohol, virus, poisons, adverse effects of drugs, poor diet, inherited conditions and obesity. Liver diseases have various types including alcoholic liver disease, non-alcoholic fatty liver disease, autoimmune hepatitis, liver cancer, hepatocellular carcinoma, liver fibrosis and hepatic inflammation. Therefore, it is imperative to find effective and efficacious agents in managing liver diseases. <i>Fusarium oxysporum</i>, an endophytic fungus and containing many bioactive compounds, could be served as a forked medication for enormous number and types of maladies. It was characterized by producing biochemical compounds which had rare pharmacological properties as it may be found in a limit number of other medicinal plants. The majority of the past researches related to <i>Fusarium oxysporum</i> recited the fungal negative field either on the pathogenic effects of the fungus on economical crops or on the fungal chemical components to know how to resist it. The present review will highlight on the bright side of <i>Fusarium oxysporum</i> and introduce the functional activities of its chemical compounds for treating its target diseases. The key point of illustrated studies in this article is displaying wide range of detected bioactive compounds isolated from <i>Fusarium oxysporum</i> and in other illustrated studies it was elucidated the therapeutical and pharmacological potency of these biologically active compounds (isolated from medicinal plants sources) against different types of liver diseases including non-alcoholic fatty liver disease, alcoholic liver disease, cirrhosis and others. It was demonstrated that <i>F. oxysporum</i> contains unique types of isoflavones, flavonoids, phenols and another active chemical compounds, and these compounds showed recently a fabulous clinical contribution in the therapy of liver injury diseases, which opens new and unprecedented way for evaluating the maintaining efficacy of <i>Fusarium oxysporum</i> bioactive compounds in dealing with hepatic complications and its remedy impacting on liver diseases and injured hepatocytes through recommending implement a practical study."], "CopyrightInformation": "\u00a9 2024 The Authors."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "National R & D Center for Edible Fungus Processing Technology, Henan University, Kaifeng, 475004, China."}, {"Identifier": [], "Affiliation": "Microbial Chemistry Department, Biotechnology Research Institute, National Research Center, Cairo, Egypt."}], "LastName": "Shalapy", "ForeName": "Nashwa M", "Initials": "NM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "National R & D Center for Edible Fungus Processing Technology, Henan University, Kaifeng, 475004, China."}], "LastName": "Liu", "ForeName": "Ming", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "National R & D Center for Edible Fungus Processing Technology, Henan University, Kaifeng, 475004, China."}, {"Identifier": [], "Affiliation": "Joint International Research Laboratory of Food & Medicine Resource Function, Henan Province, Kaifeng, 475004, China."}], "LastName": "Kang", "ForeName": "Wenyi", "Initials": "W"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Heliyon", "NlmUniqueID": "101672560", "ISSNLinking": "2405-8440"}, "CoiStatement": "The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Wenyi Kang reports financial support was provided by Research on Precision Nutrition and Health Food, 10.13039/501100006407Department of Science and Technology of Henan Province (CXJD2021006). Wenyi Kang reports a relationship with Research on Precision Nutrition and Health Food, 10.13039/501100006407Department of Science and Technology of Henan Province (CXJD2021006). that includes: funding grants. There is no room for wrong interpretation by the reader as conflict of interest."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Seitz H.K., Neuman M.G. The history of alcoholic liver disease: from an unrecognized disease to one of the most frequent diseases in hepatology. J. Clin. Med. 2021;10(4):858.", "ArticleIdList": ["PMC7921942", "33669694"]}, {"Citation": "World Health Organization (Who) 2014. Global Status Report on Alcohol and Health."}, {"Citation": "Sivakrishnan S. Liver diseases-an overview. World J. Pharm. Pharmaceut. Sci. 2019;8(1):1385\u20131395."}, {"Citation": "Zhang C., Liu S., Yang M. Antioxidant and anti-inflammatory agents in chronic liver diseases: molecular mechanisms and therapy. World J. Hepatol. 2023;15(2):180\u2013200.", "ArticleIdList": ["PMC10011909", "36926234"]}, {"Citation": "Embade N., Millet O. Molecular determinants of chronic liver disease as studied by NMR-Metabolomics. Curr. Top. Med. Chem. 2017;17:2752\u20132766.", "ArticleIdList": ["28685692"]}, {"Citation": "Seitz H.K., Bataller R., Cortez-Pinto H., Gao B., Gual A., Lackner C., Mathurin P., Mueller S., Szabo G., Tsukamoto H. Alcoholic liver disease. Nat. Rev. Dis. Prim. 2018;4:16.", "ArticleIdList": ["30115921"]}, {"Citation": "Mantovani A., Beatrice G., Dalbeni A. Coronavirus disease 2019 and prevalence of chronic liver disease: a meta-analysis. Liver Int. 2020;40:1316\u20131320.", "ArticleIdList": ["32329563"]}, {"Citation": "Munoz S.J., Maddrey W.C. Major complications of acute and chronic liver disease. Gastroenterol. Clin. N. Am. 1988;17(2):265\u2013287.", "ArticleIdList": ["3049345"]}, {"Citation": "Arshad M., Asif H., John A., Pasha M.O. Chronic liver disease and it's complications. J. Zool. 2021;4(1):3\u20137."}, {"Citation": "Hayward K.L., Weersink R.A. Improving medication\u2010related outcomes in chronic liver disease. Hepatol Commun. 2020;4(11):1562\u20131577.", "ArticleIdList": ["PMC7603526", "33163829"]}, {"Citation": "Luper S. A review of plants used in the treatment of liver disease: part 1. Alternative Med. Rev. 1998;3(6):410\u2013421.", "ArticleIdList": ["9855566"]}, {"Citation": "Jeong J., Park H.J., Cha M.G., Park E., Won S., Ganesan R., Gupta H., Gebru Y.A., Sharma S.P., Lee S.B., Kwon G.H., Jeong M.K., Min B.H., Hyun J.Y., Eom J.A., Yoon S.J., Choi M.R., Kim D.J., Suk K.T. The lactobacillus as a probiotic: focusing on liver diseases. Microorg. 2022;10(2):288.", "ArticleIdList": ["PMC8879051", "35208742"]}, {"Citation": "Gustavo G., Marianella R., Magdalena M., Eduardo P., Mar\u00eda P.A. Endophytic fungi in medicinal plants of northeast of Argentina: I: morphotaxonomic approach of their foliar community. Bol. Micol. 2010;25:15\u201327."}, {"Citation": "Ibrahim S.R.M., Sirwi A., Eid B.G., Mohamed S.G.A., Mohamed G.A. Bright side of Fusarium oxysporum: secondary metabolites bioactivities and industrial relevance in biotechnology and nanotechnology. J Fungi (Basel). 2021;7(11):943.", "ArticleIdList": ["PMC8625159", "34829230"]}, {"Citation": "Hastutia U.S., Al Asna P.M., Rahmawati D. Histologic observation, identification, and secondary metabolites analysis of endophytic fungi isolated from a medicinal plant, hedychium acuminatum roscoe. AIP Conf. Proc. 2002;(1) (2018) 020070-1\u2013020070-8."}, {"Citation": "Matsakas L., Giannakou M., V\u00f6r\u00f6s D. Effect of synthetic and natural media on lipid production from Fusarium oxysporum. Electron. J. Biotechnol. 2017;30:95\u2013102."}, {"Citation": "Brodhun F., Cristobal-Sarramian A., Zabel S., Newie J., Hamberg M., Feussner I. An iron 13S-lipoxygenase with an \u03b1-linolenic acid specific hydroperoxidase activity from Fusarium oxysporum. PLoS One. 2013;8(5)", "ArticleIdList": ["PMC3669278", "23741422"]}, {"Citation": "Quarters A.B.M., Wirgau N.E., Lehnert N. Model complexes of key intermediates in fungal cytochrome P450 nitric oxide reductase (P450nor) Curr. Opin. Chem. Biol. 2014;19:82\u201389.", "ArticleIdList": ["24658055"]}, {"Citation": "Sakai Y., Yoshida N., Isogai A., Tani Y., Kato N. Purification and properties of fructosyl lysine oxidase from Fusarium oxysporum S-1F4. Biosci. Biotechnol. Biochem. 1995;59:487\u2013491.", "ArticleIdList": ["7766189"]}, {"Citation": "Bisakowski B., Kermasha S., Klopfenstein M. Partial purified lipoxygenase from Fusarium oxysporum: characterization and kinetic studies. Process Biochem. 1995;30:261\u2013268."}, {"Citation": "Zhao Z., Ramachandran P., Kim T.S., Chen Z., Jeya M., Lee J.K. Characterization of an acid-tolerant \u03b2-1,4-glucosidase from Fusarium oxysporum and its potential as an animal feed additive. Appl. Microbiol. Biotechnol. 2013;97:10003\u201310011.", "ArticleIdList": ["23604557"]}, {"Citation": "Sakamoto T., Tsujitani Y., Fukamachi K., Taniguchi Y., Ihara H. Identification of two GH27 bifunctional proteins with \u03b2-L-arabinopyranosidase/\u03b1-D-galactopyranosidase activities from Fusarium oxysporum. Appl. Microbiol. Biotechnol. 2010;86:1115\u20131124.", "ArticleIdList": ["19937437"]}, {"Citation": "Yano T., Yamamoto K., Kumagai H., Tochikura T., Yokoyama T., Seno T., Yamaguchi H. Purification and characterization of a novel \u03b1-L-fucosidase from Fusarium oxysporum grown on sludge. Agric. Biol. Chem. 1985;49:3179\u20133187."}, {"Citation": "Ahmed A.A., Hamzah H., Maaroof M. Analyzing formation of silver nanoparticles from the filamentous fungus Fusarium oxysporum and their antimicrobial activity. Turk. J. Biol. 2018;42:54\u201362.", "ArticleIdList": ["PMC6353250", "30814870"]}, {"Citation": "Mohanpuria P., Rana N.K., Yadav S.K. Biosynthesis of nanoparticles: technological concepts and future applications. J. Nanoparticle Res. 2008;10:507\u2013517."}, {"Citation": "Caicedo N.H., Davalos A.F., Puente P.A., Rodr\u00edguez A.Y., Caicedo P.A. Antioxidant activity of exo\u2010metabolites produced by Fusarium oxysporum: an endophytic fungus isolated from leaves of Otoba gracilipes. Microbiol. 2019;8(10):903.", "ArticleIdList": ["PMC6813440", "31297981"]}, {"Citation": "Ahmed A.M., Mahmoud B.K., Millan-Aguinaga N., Abdelmohsen U.R., Fouad M.A. The endophytic Fusarium strains: a treasure trove of natural products. RSC Adv. 2023;13:1339\u20131369.", "ArticleIdList": ["PMC9827111", "36686899"]}, {"Citation": "Prasher P., Sharma M. Medicinal chemistry of anthranilic acid derivatives: a mini review. Drug Dev. Res. 2021;82(7):945\u2013958.", "ArticleIdList": ["34117784"]}, {"Citation": "Niemann G.J., Liem J., Hoof A.V.D.K., Niessen W.M.A. Phytoalexins, benzoxazinones, N-aroylanthranilates and N-aroylanilines, from Fusarium-infected carnation stems. Phytochemistry. 1992;31:3761\u20133767."}, {"Citation": "K\u0131l\u0131\u00e7 G., Tosun G., Bozdeveci A., Erik \u02d9I., \u00d6zt\u00fcrk E., Reis R., Sipahi H., Cora M., Karaoglu S.A., Yayl\u0131 N. Antimicrobial, cytotoxic, antiviral effects, and spectroscopic characterization of metabolites produced by Fusarium oxysporum YP9B. Record Nat. Prod. 2021;15:547\u2013567."}, {"Citation": "Nenkep V., Yun K., Son B.W. Oxysporizoline, an antibacterial polycyclic quinazoline alkaloid from the marine-mudflat-derived fungus Fusarium oxysporum. J. Antibiot. 2016;69:709\u2013711.", "ArticleIdList": ["26732255"]}, {"Citation": "Breinhold J., Ludvigsen S., Rassing B.R., Rosendahl C.N., Nielsen S.E., Olsen Oxysporidinone C.E. A novel, antifungal N-methyl-4-hydroxy-2-pyridone from Fusarium oxysporum. J. Nat. Prod. 1997;60:33\u201335.", "ArticleIdList": ["9014349"]}, {"Citation": "Wang Q.X., Li S.F., Zhao F., Dai H.Q., Bao L., Ding R., Gao H., Zhang L.X., Wen H.A., Liu H.W. Chemical constituents from endophytic fungus Fusarium oxysporum. Fitoterapia. 2011;82:777\u2013781.", "ArticleIdList": ["21497643"]}, {"Citation": "Lee H.S., Song H.H., Jeong J.H., Shin C.G., Choi S.U., Lee C. Cytotoxicities of enniatins H, I, and MK1688 from Fusarium oxysporum KFCC 11363P. Toxicon. 2008;51:1178\u20131185.", "ArticleIdList": ["18394672"]}, {"Citation": "Jarocka-Karpowicz I., Markowska A. Therapeutic potential of jasmonic acid and its derivatives. Int. J. Mol. Sci. 2021;22:8437.", "ArticleIdList": ["PMC8395089", "34445138"]}, {"Citation": "Shalapy N.M., Kang W. Fusarium oxysporum & Fusarium solani: identification, characterization, and differentiation the fungal phenolic profiles by HPLC and the fungal lipid profiles by GC-MS. J. Food Qual. 2022;2022:1\u201312."}, {"Citation": "Huang Z., Yang J., She Z., Lin Y. Isoflavones from the mangrove endophytic fungus Fusarium sp. (ZZF41) Nat. Prod. Commun. 2010;5(11):1771. 1773.", "ArticleIdList": ["21213977"]}, {"Citation": "Edmondson R.D., Gadda G., Fitzpatrick P.F., Russell D.H. Identification of native flavin adducts from Fusarium oxysporum using accurate mass matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Anal. Chem. 1997;69:2862\u20132865."}, {"Citation": "Kundu A., Saha S., Walia S., Dutta T.K. Anti-nemic secondary metabolites produced by Fusarium oxysporum f. sp. Ciceris. J. Asia Pac. Entomol. 2016;19:631\u2013636."}, {"Citation": "Tatum J.H., Baker R.A., Berry R.E. Naphthoquinones produced Fusarium oxysporum isolated from citrus. Phytochemistry. 1985;24:457\u2013459."}, {"Citation": "Baker R.A., Tatum J.H., Nemec S., Jr. Antimicrobial activity of naphthoquinones from Fusaria. Mycopathologia. 1990;111:9\u201315.", "ArticleIdList": ["2233983"]}, {"Citation": "Tatum J.H., Baker R.A., Berry R.E. Naphthofurans produced Fusarium oxysporum isolated from citrus. Phytochemistry. 1987;26:2499\u20132500."}, {"Citation": "Zhan J., Burns A.M., Liu M.X., Faeth S.H., Gunatilaka A.A. Search for cell motility and angiogenesis inhibitors with potential anticancer activity: beauvericin and other constituents of two endophytic strains of Fusarium oxysporum. J. Nat. Prod. 2007;70:227\u2013232.", "ArticleIdList": ["PMC3361905", "17286429"]}, {"Citation": "Li-Yang Y., Lin J., Zhou B., Liu Y.G., Zhu B.Q. H1-A, a compound isolated from Fusarium oxysporum inhibits hepatitis C virus (HCV) NS3 serine protease. Chin. J. Nat. Med. 2016;14:299\u2013302.", "ArticleIdList": ["27114318"]}, {"Citation": "Starratt A.N., Madhosingh C. Sterol and fatty acid components of mycelium of Fusarium oxysporum. Can. J. Microbiol. 1967;13:1351\u20131355.", "ArticleIdList": ["6064340"]}, {"Citation": "Mohamed G.A., Ibrahim S.R.M., Alhakamy N.A., Aljohani O.S. Fusaroxazin, a novel cytotoxic and antimicrobial xanthone derivative from Fusarium oxysporum. Nat. Prod. Res. 2020;36(4):952\u2013960.", "ArticleIdList": ["33930988"]}, {"Citation": "Chen J., Bai X., Hua Y., Zhang H., Wang H. Fusariumins C and D, two novel antimicrobial agents from Fusarium oxysporum ZZP-R1 symbiotic on Rumex madaio Makino. Fitoterapia. 2019;134:1\u20134.", "ArticleIdList": ["30708045"]}, {"Citation": "Fu Y., Wu P., Xue J., Zhang M., Wei X. Cosmosporasides F-H, three new sugar alcohol conjugated acyclic sesquiterpenes from a Fusarium oxysporum fungus. Nat. Prod. Res. 2020;36(13):3420\u20133428.", "ArticleIdList": ["33375847"]}, {"Citation": "Kim K.H., Lee Y.W., Mirocha C.J., Pawlosky R.J. Isoverrucarol production by Fusarium oxysporum CJS-12 isolated from corn. Appl. Environ. Microbiol. 1990;56:260\u2013263.", "ArticleIdList": ["PMC183300", "2310181"]}, {"Citation": "Piska F., Teruna H.Y. Terpenoid as antibacterial produced by endophyte Fusarium oxysporum LBKURCC41 from Dahlia variabilis tuber. J. Phys. Conf. Ser. 2020;1655"}, {"Citation": "Cui Y., Yi D., Bai X., Sun B., Zhao Y., Zhang Y. Ginkgolide B produced endophytic fungus (Fusarium oxysporum) isolated from Ginkgo biloba. Fitoterapia. 2012;83:913\u2013920.", "ArticleIdList": ["22537641"]}, {"Citation": "Nasr H.M.D., Abdel-ghany R.O., Mousa S.A.S., Alasmaey M., Atalla A.A. Biological activity of crude extracts of endophytic Fusarium Oxysporum and its chemical composition by gas chromatography\u2013mass spectrometry. Elixir Org. Chem. 2018;117:50565\u201350568."}, {"Citation": "Yu R., Li M., Wang Y., Bai X., Chen J., Li X., Wang H., Zhang H. Chemical investigation of a co-culture of Aspergillus fumigatus D and Fusarium oxysporum R1. Record Nat. Prod. 2021;15:130\u2013135."}, {"Citation": "Nascimento A.M., Conti R., Turatti I.C.C., Cavalcanti B.C., Costa-Lotufo L.V., Pessoa C., Moraes M.O., Manfrim V., Toledo J.S., Cruz A.K., Pupo M.T. Bioactive extracts and chemical constituents of two endophytic strains of Fusarium oxysporum. Brazilian Journal of Pharmacognosy. 2012;22(6):1276\u20131281."}, {"Citation": "Nita-Lazar M., Heyraud A., Gey C., Braccini I., Lienart Y. Novel oligosaccharides isolated from Fusarium oxysporum L. rapidly induce PAL activity in Rubus cells. Acta Biochim. Pol. 2004;51:625\u2013647.", "ArticleIdList": ["15448725"]}, {"Citation": "Al-Rubaye A.F., Hameed I.H., Kamal S.A. Screening of metabolites products of Fusarium oxysporum and determination of its antibacterial and antifungal activity using medicinal plants extract. Indian Journal of Public Health Research & Develop. 2018;9(3):400\u2013404."}, {"Citation": "Zhao J., Fu Y., Luo M., Zu Y., Wang W., Zhao C., Gu C. Endophytic fungi from pigeon pea [Cajanus cajan (L.) Mill sp.] produce antioxidant Cajaninstilbene acid. J. Agric. Food Chem. 2012;60(17):4314\u20134319.", "ArticleIdList": ["22494407"]}, {"Citation": "Toghueo R.M.K. Bioprospecting endophytic fungi from Fusarium genus as sources of bioactive metabolites. Mycology. 2020;11(1):1\u201321.", "ArticleIdList": ["PMC7033707", "32128278"]}, {"Citation": "Grover J.K., Yadav S., Vats V. Medicinal plants of India with anti-diabetic potential. J. Ethnopharmacol. 2002;81(1):81\u2013100.", "ArticleIdList": ["12020931"]}, {"Citation": "Strobel G., Daisy B., Castillo U. The biological promise of microbial endophytes and their natural products. Plant Pathol. J. 2005;4(2):161\u2013176."}, {"Citation": "Mutha R.E., Tatiya A.U., Surana S.J. Flavonoids as natural phenolic compounds and their role in therapeutics: an overview. Futur J Pharm Sci. 2021;7(1):25.", "ArticleIdList": ["PMC7816146", "33495733"]}, {"Citation": "Shi A., Li T., Zheng Y., Song Y., Wang H., Wang N., Dong L., Shi H. Chlorogenic acid improves NAFLD by regulating gut microbiota and GLP-1. Front. Pharmacol. 2021;12", "ArticleIdList": ["PMC8278021", "34276380"]}, {"Citation": "Abunofal O., Mohan C. Salubrious effects of green tea catechins on fatty liver disease: a Systematic Review. Medicines (Basel). 2022;9(3):20.", "ArticleIdList": ["PMC8949532", "35323719"]}, {"Citation": "Akbari G., Savari F., Mard S.A., Rezaie A., Moradi M. Gallic acid protects the liver in rats against injuries induced by transient ischemia-reperfusion through regulating microRNAs expressions. Iran J Basic Med Sci. 2019;22(4):439\u2013444.", "ArticleIdList": ["PMC6535206", "31168350"]}, {"Citation": "Parvizi F., Yaghmaei P., Rohani S.A.H., Mard S.A. Hepatoprotective properties of p-coumaric acid in a rat model of ischemia-reperfusion. Avicenna J Phytomed. 2020;10(6):633\u2013640.", "ArticleIdList": ["PMC7711293", "33299819"]}, {"Citation": "Mu M., Zuo S., Wu R., Deng K., Lu S., Zhu J., Zou G., Yang J., Cheng M., Zhao X. Ferulic acid attenuates liver fibrosis and hepatic stellate cell activation via inhibition of TGF-\u03b2/Smad signaling pathway. Drug Des. Dev. Ther. 2018;12:4107\u20134115.", "ArticleIdList": ["PMC6284527", "30584275"]}, {"Citation": "Ghanim A.M.H., Younis N.S., Metwaly H.A. Vanillin augments liver regeneration effectively in Thioacetamide induced liver fibrosis rat model. Life Sci. 2021;286", "ArticleIdList": ["34637793"]}, {"Citation": "Hern\u00e1ndez-Aquino E., Muriel P. Beneficial effects of naringenin in liver diseases: molecular mechanisms. World J. Gastroenterol. 2018;24(16):1679\u20131707.", "ArticleIdList": ["PMC5922990", "29713125"]}, {"Citation": "Kim M., Park J., Jung J., Byun K., Kang K., Lee Y. Daidzein supplementation prevents non-alcoholic fatty liver disease through alternation of hepatic gene expression profiles and adipocyte metabolism. Int. J. Obes. 2011;35(8):1019\u20131030.", "ArticleIdList": ["21157426"]}, {"Citation": "Alkandahri M.Y., Pamungkas B.T., Oktoba Z., Shafirany M.Z., Sulastri L., Arfania M., Anggraeny E.N., Pratiwi A., Astuti F.D., Dewi S.Y.I., Hamidah S.Z. Hepatoprotective effect of kaempferol: a review of the dietary sources, bioavailability, mechanisms of action, and safety. Adv Pharmacol Pharm Sci. 2023;2023", "ArticleIdList": ["PMC9988374", "36891541"]}, {"Citation": "AlSharari S.D., Al-Rejaie S.S., Abuohashish H.M., Ahmed M.M., Hafez M.M. Rutin attenuates hepatotoxicity in high-cholesterol-diet-fed rats. Oxid. Med. Cell. Longev. 2016;2016", "ArticleIdList": ["PMC4863108", "27239252"]}, {"Citation": "Lee W., Kim S. Protective effects of isoflavones on alcoholic liver diseases: computational approaches to investigate the inhibition of ALDH2 with isoflavone analogues. Front. Mol. Biosci. 2023;10:2023.", "ArticleIdList": ["PMC10009234", "36923641"]}, {"Citation": "Yao L., Nisar M.F., Yan T., Wan C. Potential effects of dietary isoflavones on drug-induced liver injury. J. Food Qual. 2021;2021"}, {"Citation": "Prasher P., Sharma M. Medicinal chemistry of anthranilic acid derivatives: a mini review. Drug Dev. Res. 2021;82:945\u2013958.", "ArticleIdList": ["34117784"]}, {"Citation": "Saito H., Ebinuma H., Tadal S., Tsunematsu S., Atsukawa K., Masuda T., Tsuchiya M., Ishii H. Enhancing effect of the liver extract and flavin adenin dinucleotide mixture on anti-viral efficacy of interferon in patients with chronic hepatitis C. Keio J. Med. 1996;45(1):48\u201353.", "ArticleIdList": ["8882468"]}, {"Citation": "Wang Y., Luo Y., Piao X., Shen G., Meng L., Zhang Y., Wang J., Li J., Wang H., Xu W., Liu Y., Zhang Y., Zhang T., Wang S., Sun H., Han Y., Jin M., Zang Y., Zhang D., Jin C. Novel 1,4-naphthoquinone derivatives induce reactive oxygen species-mediated apoptosis in liver cancer cells. Mol. Med. Rep. 2019;19:1654\u20131664.", "ArticleIdList": ["PMC6390020", "30592276"]}, {"Citation": "Yang W., Chen X., Li Y., Guo S., Wang Z., Yu X. Advances in pharmacological activities of terpenoids. Nat. Prod. Commun. 2020;15(3):1\u201313."}, {"Citation": "Li-Yuan Y., Jun L., Bin Z., Yan-Gang L., Bao-Quan Z. H1-A, a compound isolated from Fusarium oxysporum inhibits hepatitis C virus (HCV) NS3 serine protease. Chin. J. Nat. Med. 2016;14(4):299\u2013302.", "ArticleIdList": ["27114318"]}, {"Citation": "Huang H., Huang H., Chiou W., Lin L., Chen J., Liu H., Lai Y., Huang C. Ergosterol peroxide inhibits HBV infection by inhibiting the binding of the pre-S1 domain of LHBsAg to NTCP. Antivir. Res. 2021;195", "ArticleIdList": ["34627935"]}, {"Citation": "Yang Y., Chen J., Gao Q., Shan X., Wang J., Lv Z. Study on the attenuated effect of Ginkgolide B on ferroptosis in high fat diet induced nonalcoholic fatty liver disease. Toxic. 2020;445", "ArticleIdList": ["32976958"]}, {"Citation": "Wang C., Liou C., Wu S., Wei C., Huang W. Ginkgolide B reduces hepatic lipid accumulation and ameliorates nonalcoholic fatty liver disease in high-fat diet\u2013induced obese mice. Oncotarget. 2018;1949:2553."}, {"Citation": "Kim S., Choi Y., Choi S., Choi Y., Park T. Dietary camphene attenuates hepatic steatosis and insulin resistance in mice. Obesity. 2014;22(2):408\u2013417.", "ArticleIdList": ["23818423"]}, {"Citation": "Selvaraj J. Fatty Acids. InTech.; 2017. Fatty acids and their analogues as anticancer agents.", "ArticleIdList": ["10.5772/intechopen.68171"]}, {"Citation": "Casillas-Vargas G., Ocasio-Malav\u00e9 C., Medina S., Morales-Guzm\u00e1n C., Valle R.G.D., Carballeira N.M., Sanabria-R\u00edos D.J. Antibacterial fatty acids: an update of possible mechanisms of action and implications in the development of the next-generation of antibacterial agents. Prog. Lipid Res. 2021;82", "ArticleIdList": ["PMC8137538", "33577909"]}, {"Citation": "Ducheix S., Montagner A., Polizzi A., Lasserre F., R\u00e9gnier M., Marmugi A., Benhamed F., Bertrand-Michel J., Mselli-Lakhal L., Loiseau N., Martin P.G., Lobaccaro J., Ferrier L., Postic C., Guillou H. Dietary oleic acid regulates hepatic lipogenesis through a liver X receptor-dependent signaling. PLoS One. 2017;12(7)", "ArticleIdList": ["PMC5521785", "28732092"]}, {"Citation": "Nagao K., Inoue N., Wang Y., Shirouchi B., Yanagita T. Dietary conjugated linoleic acid alleviates nonalcoholic fatty liver disease in Zucker (fa/fa) Rats. J. Nutr. 2005;135(1):9\u201313.", "ArticleIdList": ["15623825"]}, {"Citation": "Souza C.O., Teixeira A.A.S., Biondo L.A., Silveira L.S., Breda C.N.S., Braga T.T., Camara N.O.S., Belchior T., Festuccia W.T., Diniz T.A., Ferreira G.M., Hirata M.H., Chaves-Filho A.B., Yoshinaga M.Y., Miyamoto S., Calder P.C., Sethi J.K., Neto J.C.R. Palmitoleic acid reduces high fat diet-induced liver inflammation by promoting PPAR-\u03b3-independent M2a polarization of myeloid cells. Biochim. Biophys. Acta Mol. Cell Biol. Lipids. 2020;1865(10)", "ArticleIdList": ["PMC7487782", "32738301"]}, {"Citation": "Zhang L., Li H., Pan W., Khan F.U., Qian C., Qi-Li F., Xu X. Administration of methyl palmitate prevents non-alcoholic steatohepatitis (NASH) by induction of PPAR-\u03b1. Biomed. Pharmacother. 2019;111:99\u2013108.", "ArticleIdList": ["30579258"]}, {"Citation": "Spriha S.E., Abdur-Rahman S.M. A review on biological activities of sugars and sugar derivatives. J. Pharmaceut. Sci. 2022;20(3):381\u2013394."}, {"Citation": "Pani A., Giossi R., Menichelli D., Fittipaldo V.A., Agnelli F., Inglese E., Romandini A., Roncato R., Pintaudi B., Sole F.D., Scaglione F. Inositol and non-alcoholic fatty liver disease: a systematic review on deficiencies and supplementation. Nutrients. 2020;12(11):3379.", "ArticleIdList": ["PMC7694137", "33153126"]}, {"Citation": "Kirpich A., Ragavan M., Bankson J.A., McIntyre L.M., Merritt M.E. Kinetic analysis of hepatic metabolism using hyperpolarized dihydroxyacetone. J. Chem. Inf. Model. 2019;59(1):605\u2013614.", "ArticleIdList": ["PMC6533070", "30602117"]}, {"Citation": "Wang Y., Zhao J., Li Q., Liu J., Sun Y., Zhang K., Fan M., Qian H., Li Y., Wang L. L-Arabinose improves hypercholesterolemia via regulating bile acid metabolism in high-fat-high-sucrose diet-fed mice. Nutr. Metab. 2022;2022:19\u201330.", "ArticleIdList": ["PMC9013033", "35428331"]}, {"Citation": "Xu M., Huang Z., Zhu W., Liu Y., Bai X., Zhang H. Fusarium-derived secondary metabolites with antimicrobial effects. Molecules. 2023;28(8):3424.", "ArticleIdList": ["PMC10142451", "37110658"]}, {"Citation": "Yan M., Jin S., Liu Y., Wang L., Wang Z., Xia T., Chang Q. Cajaninstilbene acid ameliorates acetaminophen-induced liver injury through enhancing sestrin2/AMPK-mediated mitochondrial quality control. Front. Pharmacol. 2022;13", "ArticleIdList": ["PMC8957965", "35350766"]}, {"Citation": "Huang M., Lin J., Lu K., Xu H., Geng Z., Sun P., Chen W. Anti-Inflammatory effects of cajaninstilbene acid and its derivatives. J. Agric. Food Chem. 2016;64(14):2893\u20132900.", "ArticleIdList": ["26998619"]}, {"Citation": "Mols P., Hallemans R., Melot C., Lejeune P., Naeije R. Systemic and regional hypodynamic effects of isosorbide dinitrate in patients with liver cirrhosis and portal hypertension. J. Hepatol. 1989;8(3):316\u2013324.", "ArticleIdList": ["2732445"]}, {"Citation": "Cervinka J., Kordac V., Kalab M. Effect of peroral administration of isosorbide dinitrate on portal pressure and blood flow in patients with cirrhosis of the liver. J. Int. Med. Res. 1989;17:560\u2013564.", "ArticleIdList": ["2628133"]}, {"Citation": "Jiang Z., Ma Y., Li M., Zhan X., Zhang X., Wang M. 5-Hydroxymethylfurfural protects against ER stress-induced apoptosis in GalN/TNF-\u03b1-injured L02 hepatocytes through regulating the PERK-eIF2\u03b1 signaling pathway. Chin. J. Nat. Med. 2015;13(12):896\u2013905.", "ArticleIdList": ["26721708"]}, {"Citation": "Li W., Qu X., Han Y., Zheng S., Wang J., Wang Y. Ameliorative effects of 5-hydroxymethyl-2-furfural (5-HMF) from Schisandra chinensis on alcoholic liver oxidative injury in mice. Int. J. Mol. Sci. 2015;16:2446\u20132457.", "ArticleIdList": ["PMC4346845", "25622257"]}, {"Citation": "Wu X., Sun Y., Guo W., Gu Y., Wu X., Tan R., Xu Q. Rebuilding the balance of STAT1 and STAT3 signalings by fusaruside, a cerebroside compound, for the treatment of T-cell-mediated fulminant hepatitis in mice. Biochem. Pharmacol. 2012;84(9):1164\u20131173.", "ArticleIdList": ["22902832"]}, {"Citation": "Tian Y., Zhao G.Y., Fang W., Xu Q., Tan R.X. \u039410(E)-sphingolipid desaturase involved in fusaruside mycosynthesis and stress adaptation in Fusarium graminearum, Sci Rep. 2015;5", "ArticleIdList": ["PMC4440215", "25994332"]}]}], "History": [{"Year": "2023", "Month": "9", "Day": "23"}, {"Year": "2024", "Month": "1", "Day": "29"}, {"Year": "2024", "Month": "2", "Day": "15"}, {"Year": "2024", "Month": "3", "Day": "8", "Hour": "6", "Minute": "44"}, {"Year": "2024", "Month": "3", "Day": "8", "Hour": "6", "Minute": "43"}, {"Year": "2024", "Month": "3", "Day": "8", "Hour": "4", "Minute": "1"}, {"Year": "2024", "Month": "2", "Day": "20"}], "PublicationStatus": "epublish", "ArticleIdList": ["38455549", "PMC10918022", "10.1016/j.heliyon.2024.e26562", "S2405-8440(24)02593-3"]}}]}